|
1) Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicopathological features of moyamoya disease in Japan: Findings from a national epidemiological survey. Stroke. 2008; 39: 42-7
|
|
|
|
2) Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry. 2008; 79: 900-4
|
|
|
|
|
3) Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008; 39: 3193-200
|
|
|
|
|
|
4) Derdeyn CP. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009; 361: 97
|
|
|
|
|
|
5) Takagi Y, Kikuta K, Nozaki, et al. Histological features of middle cerebral arteries from patients treated for moyamoya disease. Neurol Med Chir(Tokyo). 2007; 47, 1-4
|
|
|
|
|
|
6) Takagi Y, Kikuta K, Nozaki, et al. Expression of hypoxia-inducing factor 1alpha and endglin in intimal hyperplasia of the middle cerebral artery of patients with moyamoya adisease. Neurosurgery. 2007; 60, 338-45
|
|
|
|
|
|
7) Sakamoto S, Kiura Y, Yamasaki F, et al. Expression of vascular endothelial growth factor in dura matter of patients with moymoaya disease. Neurosurg Rev. 2008; 31: 77-81
|
|
|
|
|
|
8) Fujimura M, Watanabe M, Narisawa A, et al. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol. 2009 [Epub ahead of print]
|
|
|
|
|
|
9) Mineharu Y, Takenaka K, Yamanaka KH, et al. Inheritance pattern of familial moyamoya disease: Autosomal dominant mode and genemic imprinting. J Neurol Neurosurg Psychiatry. 2006; 77: 1025-9
|
|
|
|
|
|
10) Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25. 3. Neurology. 2008; 70: 2357-63
|
|
|
|
|
|
11) Houkin K, Nakayama N, Kuroda S, et al. Novel magnetic resonance angiography stage grading for moyamoya disease. Cerebrovasc Dis. 2005; 20: 347-54
|
|
|
|
|
|
12) Tanaka Y, Nariai T, Nagaoka T, et al. Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography. J Cereb Blood Flow Metab. 2006; 26: 291-300
|
|
|
|
|
|
13) Yun TJ, Cheon JE, Na DG, et al. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging-correlation with clinical outcome after revascularization surgery. Radiology. 2009; 251: 216-23
|
|
|
|
|
|
14) Mori N, Mugikura S, Higano S, et al. The leptomeningeal ‘ivy sign' on fluid attenuated inversion recovery MR imaging in moyamoya disease: a sign of decreased cerebral vascular reserve？ AJNR Am J Neuroradiol. 2009; 30: 930-5
|
|
|
|
|
|
15) Kikuta K, Takagi Y, Nozaki K, et al. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease. Neurosurgery. 2008; 62: 104-11
|
|
|
|
|
|
16) Kohama M, Fujimura M, Mugikura S, et al. Temporal profile of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease. Neurosurg Rev. 2008; 31: 451-5
|
|
|
|
|
|
17) Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg. 2009; 111: 927-35
|
|
|
|
|
|
18) Huang AP, Liu HM, Lai DM, et al. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovasc Dis. 2009; 28: 247-57
|
|
|
|
|
|
19) Hayashi T, Shirane R, Tominaga T. Additional surgery for postoperative ischemic symptoms in patients with moyamoya disease: the effectiveness of occipital artery-posterior cerebral artery bypass with an indirect procedure: technical case report. Neurosurgery. 2009; 64: E195-6
|
|
|
|
|
|
20) Miyamoto S. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset - The Japan Adult Moyamoya Trial Group. Neurol Med Chir(Tokyo). 2004; 44: 218-9
|
|
|
|
|
|
21) Fujimura M, Kaneta T, Mugikura S, et al. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol. 2007; 67: 273-82
|
|
|
|
|
|
22) Kim JE, Oh CW, Kwon OK, et al. Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis. 2008; 25: 580-6
|
|
|
|
|
|
23) Ohue S, Kumon Y, Kohno K, et al. Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol. 2008; 69: 281-6
|
|
|
|
|
|
24) Fujimura M, Mugikura S, Kaneta T, et al. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol. 2009; 71: 442-7
|
|
|
|
|
|
25) Fujimura M, Shimizu H, Mugikura S, et al. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patients with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol. 2009; 71: 223-7
|
|
|
|
|
|
26) Nakagawa A, Fujimura M, Arafune T, et al. Clinical implication of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg. 2009 [Epub ahead of print]
|
|
|
|
|
|
27) Fujimura M, Kaneta T, Shimizu H, et al. Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev. 2009; 32: 245-9
|
|
|
|
|
|
28) Kuroda S, Hashimoto N, Yoshimoto T, et al. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007; 38: 1430-5
|
|
|
|
|
|
29) Kuroda S, Ishikawa T, Houkin K, et al. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke. 2005; 36: 2148-53
|
|
|
|
|
|
30) Narisawa A, Fujimura M, Tominaga T. Efficacy of revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions. Clin Neurol Neurosurg. 2009; 111: 123-6
|
|
|
|
|